UNICYCIVE THERAPEUTICS, INC.

Analyst Reco. Unicycive Therapeutics, Inc.

Equities

UNCY

US90466Y1038

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
0.7757 ^USD	+0.74%		-11.85%	-10.60%

May. 28	Unicycive Therapeutics, Inc. Delivers Multiple Presentations on Oxylanthanum Carbonate and Uni-494 At the European Renal Association Congress	CI
May. 15	Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate At the National Kidney Foundation Spring Clinical Meeting	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Piper Sandler Initiates Coverage on Unicycive Therapeutics With Overweight Rating, $9 Price Target	Apr. 04	MT
HC Wainwright Adjusts Unicycive Therapeutics' Price Target to $4.50 From $7, Keeps Buy Rating	23-08-16	MT
Maxim Adjusts Price Target on Unicycive Therapeutics to $4 From $6, Maintains Buy Rating	23-07-03	MT
Roth MKM Adjusts Price Target on Unicycive Therapeutics to $4 From $5, Maintains Buy Rating	23-07-03	MT
EF Hutton Starts Unicycive Therapeutics at Buy With $5 Price Target	23-03-09	MT
Maxim Adjusts Price Target on Unicycive Therapeutics to $6 From $3, Maintains Buy Rating	23-03-09	MT
HC Wainwright Cuts Price Target on Unicycive Therapeutics to $8 From $9, Keeps Buy Rating	22-11-28	MT
HC Wainwright Starts Unicycive Therapeutics at Buy With $9 Price Target	22-06-08	MT
Maxim Initiates Unicycive Therapeutics at Buy with $3 Price Target	22-03-16	MT
UNICYCIVE THERAPEUTICS : Benchmark Starts Unicycive Therapeutics at Speculative Buy With $13 Price Target	21-08-17	MT
UNICYCIVE THERAPEUTICS : Roth Capital Starts Unicycive Therapeutics at Buy With $13.50 Price Target	21-08-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer